PL2178900T3 - Oczyszczanie PEGilowanych polipeptydów - Google Patents
Oczyszczanie PEGilowanych polipeptydówInfo
- Publication number
- PL2178900T3 PL2178900T3 PL08784775T PL08784775T PL2178900T3 PL 2178900 T3 PL2178900 T3 PL 2178900T3 PL 08784775 T PL08784775 T PL 08784775T PL 08784775 T PL08784775 T PL 08784775T PL 2178900 T3 PL2178900 T3 PL 2178900T3
- Authority
- PL
- Poland
- Prior art keywords
- purification
- pegylated polypeptides
- pegylated
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07013959 | 2007-07-17 | ||
| PCT/EP2008/005767 WO2009010270A2 (en) | 2007-07-17 | 2008-07-15 | Reinigung pegylierter polypeptide |
| EP08784775A EP2178900B1 (en) | 2007-07-17 | 2008-07-15 | Purification of pegylated polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2178900T3 true PL2178900T3 (pl) | 2012-10-31 |
Family
ID=40120288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08784775T PL2178900T3 (pl) | 2007-07-17 | 2008-07-15 | Oczyszczanie PEGilowanych polipeptydów |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8138317B2 (pl) |
| EP (1) | EP2178900B1 (pl) |
| JP (2) | JP5307808B2 (pl) |
| KR (1) | KR101163297B1 (pl) |
| CN (1) | CN101889023B (pl) |
| AR (2) | AR067537A1 (pl) |
| AT (1) | ATE556086T1 (pl) |
| AU (1) | AU2008277887B2 (pl) |
| BR (1) | BRPI0813830A2 (pl) |
| CA (1) | CA2692612C (pl) |
| CL (1) | CL2008002053A1 (pl) |
| DK (1) | DK2178900T3 (pl) |
| ES (1) | ES2386323T3 (pl) |
| IL (1) | IL202940A (pl) |
| PE (1) | PE20090823A1 (pl) |
| PL (1) | PL2178900T3 (pl) |
| PT (1) | PT2178900E (pl) |
| RU (1) | RU2476439C2 (pl) |
| TW (1) | TWI363060B (pl) |
| WO (1) | WO2009010270A2 (pl) |
| ZA (1) | ZA201000283B (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR067536A1 (es) * | 2007-07-17 | 2009-10-14 | Hoffmann La Roche | Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea |
| CL2008002053A1 (es) * | 2007-07-17 | 2009-05-22 | Hoffmann La Roche | Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion. |
| CA2736141C (en) * | 2008-09-23 | 2018-03-20 | F. Hoffmann-La Roche Ag | Purification of erythropoietin |
| WO2011035282A1 (en) * | 2009-09-21 | 2011-03-24 | Ge Healthcare Bio-Sciences Ab | Dual capture separation |
| JP5735650B2 (ja) * | 2010-09-14 | 2015-06-17 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｐｅｇ化エリスロポエチンを精製するための方法 |
| CN102816227A (zh) * | 2012-08-30 | 2012-12-12 | 深圳赛保尔生物药业有限公司 | 回收促红细胞生成素的方法 |
| CN105820232B (zh) * | 2016-04-08 | 2019-05-17 | 昂德生物药业有限公司 | 单修饰聚乙二醇重组人促红素的制备方法及其制品和应用 |
| CA3027143A1 (en) * | 2016-07-15 | 2018-01-18 | F. Hoffmann-La Roche Ag | Method for purifying pegylated erythropoietin |
| ES2905105T3 (es) | 2017-12-29 | 2022-04-07 | Hoffmann La Roche | Procedimiento para proporcionar una composición de proteína PEGilada |
| CN111727063A (zh) * | 2017-12-29 | 2020-09-29 | 豪夫迈·罗氏有限公司 | 用于提供聚乙二醇化蛋白质组合物的方法 |
| JP7137625B2 (ja) * | 2017-12-29 | 2022-09-14 | エフ．ホフマン－ラ ロシュ アーゲー | Ｐｅｇ化タンパク質組成物を提供するための方法 |
| US20220017570A1 (en) * | 2018-11-05 | 2022-01-20 | Bristol-Meyers Squibb Company | Method for purifying pegylated protein |
| WO2021072210A1 (en) * | 2019-10-11 | 2021-04-15 | Coherus Biosciences, Inc. | Methods of purifying ranibizumab or a ranibizumab variant |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5118796A (en) * | 1987-12-09 | 1992-06-02 | Centocor, Incorporated | Efficient large-scale purification of immunoglobulins and derivatives |
| FR2646438B1 (fr) | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
| DK0747485T3 (da) | 1989-11-06 | 1999-08-16 | Cell Genesys Inc | Fremstilling af proteiner ved anvendelse af homolog rekombination |
| DE69031172T2 (de) | 1989-12-22 | 1998-03-12 | Applied Research Systems | Modifikation der endogenen genexpression mit hilfe eines regulatorischen elements mittels homologe rekombination |
| FR2656531B1 (fr) | 1989-12-29 | 1992-04-24 | Sanofi Sa | Promoteur artificiel pour l'expression de proteines dans le levure. |
| JPH04218000A (ja) | 1990-02-13 | 1992-08-07 | Kirin Amgen Inc | 修飾ポリペプチド |
| JP2826362B2 (ja) | 1990-02-13 | 1998-11-18 | 三井化学株式会社 | オレフィン重合用固体触媒の製造方法、オレフィン重合用固体触媒およびオレフィンの重合方法 |
| JP3051145B2 (ja) * | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
| CH686212A5 (de) | 1992-03-07 | 1996-02-15 | Buehler Ag Geb | Verfahren und Vorrichtung zur Manipulation und Portionieren von langen Teigwaren. |
| DE4118912C1 (pl) | 1991-06-08 | 1992-07-02 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
| EP0536447A1 (en) | 1991-10-11 | 1993-04-14 | Koninklijke Emballage Industrie Van Leer B.V. | Exposure meter for use with induction heat sealing of containers |
| US5968502A (en) | 1991-11-05 | 1999-10-19 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5641670A (en) * | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| PT101031B (pt) | 1991-11-05 | 2002-07-31 | Transkaryotic Therapies Inc | Processo para o fornecimento de proteinas por terapia genetica |
| FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| ATE225801T1 (de) * | 1992-07-13 | 2002-10-15 | Bionebraska Inc | Verfahren zur modifizierung rekombinanter polypeptide |
| US5264555A (en) | 1992-07-14 | 1993-11-23 | Enzon, Inc. | Process for hemoglobin extraction and purification |
| TW402639B (en) | 1992-12-03 | 2000-08-21 | Transkaryotic Therapies Inc | Protein production and protein delivery |
| US5437989A (en) * | 1992-12-30 | 1995-08-01 | Hoffmann-La Roche Inc. | Alcohol/aldehyde dehydrogenase from Gluconobacter oxydans DSM 4025 FERM BP-3812 |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| IL118201A (en) * | 1995-05-11 | 2004-12-15 | Roche Diagnostics Gmbh | Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof |
| DE19535571A1 (de) * | 1995-09-14 | 1997-03-20 | Boehringer Mannheim Gmbh | Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten |
| TW518219B (en) | 1996-04-26 | 2003-01-21 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
| EP0885613A1 (de) | 1997-06-21 | 1998-12-23 | Roche Diagnostics GmbH | Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin |
| AU7907398A (en) | 1997-06-23 | 1999-01-04 | Novo Nordisk A/S | Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function |
| US7101838B2 (en) * | 1997-08-05 | 2006-09-05 | The Trustees Of Columbia University In The City Of New York | Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts |
| DE19734293A1 (de) | 1997-08-08 | 1999-02-11 | Boehringer Mannheim Gmbh | Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen |
| BR9917606A (pt) * | 1998-11-06 | 2002-12-31 | Bio Sidus S A | Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento |
| WO2000044786A1 (en) | 1999-01-26 | 2000-08-03 | Neurosearch A/S | Novel potassium channels and genes encoding these potassium channels |
| KR100689212B1 (ko) | 1999-01-29 | 2007-03-09 | 암겐 인코포레이티드 | Ｇｃｓｆ 결합체 |
| US6583273B1 (en) | 1999-05-10 | 2003-06-24 | Ciba Specialty Chemicals Corporation | Azo dyes, process for their preparation and their use for dyeing or printing natural or synthetic materials |
| DE19930177B4 (de) | 1999-06-30 | 2007-02-08 | Nikolai Vladimirovich Bovin | Intermolekular assoziierende Verbindungen und deren Verwendung |
| PE20010288A1 (es) | 1999-07-02 | 2001-03-07 | Hoffmann La Roche | Derivados de eritropoyetina |
| CZ299516B6 (cs) * | 1999-07-02 | 2008-08-20 | F. Hoffmann-La Roche Ag | Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem |
| JP5179689B2 (ja) * | 2000-02-11 | 2013-04-10 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗体ベース融合タンパク質の循環系内半減期の増強 |
| US6586398B1 (en) | 2000-04-07 | 2003-07-01 | Amgen, Inc. | Chemically modified novel erythropoietin stimulating protein compositions and methods |
| US20050100991A1 (en) * | 2001-04-12 | 2005-05-12 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| ATE291436T2 (de) * | 2000-05-15 | 2005-04-15 | Hoffmann La Roche | Flüssige arzneizubereitung enthaltend ein erythropoietin derivat |
| CA2431964C (en) * | 2000-12-20 | 2013-09-10 | F. Hoffmann-La Roche Ag | Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| US6930086B2 (en) | 2001-09-25 | 2005-08-16 | Hoffmann-La Roche Inc. | Diglycosylated erythropoietin |
| US6797299B2 (en) | 2002-02-05 | 2004-09-28 | Great Wall Enterprise Co., Ltd. | Desalting method for nutritional supplements with animal protein |
| SE526227C2 (sv) | 2002-05-15 | 2005-08-02 | North China Pharmaceutical Group | Metod för rening av rekombinant humant serumalbumin |
| WO2004009627A1 (en) * | 2002-07-19 | 2004-01-29 | Cangene Corporation | Pegylated erythropoietic compounds |
| RU2318004C2 (ru) * | 2002-07-24 | 2008-02-27 | Ф.Хоффманн-Ля Рош Аг | Добавки в виде полиалкиленгликолевой кислоты |
| LT1543038T (lt) | 2002-09-11 | 2017-07-10 | Genentech, Inc. | Baltymo gryninimas |
| US7610156B2 (en) * | 2003-03-31 | 2009-10-27 | Xencor, Inc. | Methods for rational pegylation of proteins |
| US20050008649A1 (en) | 2003-06-02 | 2005-01-13 | University Of Miami | Chimeric molecules and methods of use |
| SE0401951D0 (sv) | 2004-07-29 | 2004-07-29 | Amersham Biosciences Ab | Chromatography method |
| BRPI0519430A2 (pt) * | 2004-12-22 | 2009-02-10 | Ambrx Inc | hormânio do crescimento humano modificado |
| US20080230478A1 (en) * | 2005-05-24 | 2008-09-25 | Ge Healthcare Bio-Sciences Ab | Regeneration Of A Chromatography Matrix |
| TWI391399B (zh) * | 2005-05-25 | 2013-04-01 | Hoffmann La Roche | 測定溶離多肽之鹽濃度之方法 |
| GB2428018B (en) | 2005-07-06 | 2010-07-28 | Acco Uk Ltd | Stapling device |
| US20070072795A1 (en) | 2005-09-28 | 2007-03-29 | Anton Haselbeck | Treatment of neurodegenerative disorders |
| ES2357152T3 (es) | 2005-10-04 | 2011-04-19 | Zymogenetics, L.L.C. | Producción y purificación de il-29. |
| WO2008010061A2 (en) | 2006-07-17 | 2008-01-24 | Glenmark Pharmaceuticals S.A. | 3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |
| CL2008002053A1 (es) * | 2007-07-17 | 2009-05-22 | Hoffmann La Roche | Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion. |
| AR067536A1 (es) * | 2007-07-17 | 2009-10-14 | Hoffmann La Roche | Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea |
-
2008
- 2008-07-14 CL CL2008002053A patent/CL2008002053A1/es unknown
- 2008-07-14 AR ARP080103023A patent/AR067537A1/es active IP Right Grant
- 2008-07-15 PL PL08784775T patent/PL2178900T3/pl unknown
- 2008-07-15 EP EP08784775A patent/EP2178900B1/en active Active
- 2008-07-15 DK DK08784775.2T patent/DK2178900T3/da active
- 2008-07-15 CA CA2692612A patent/CA2692612C/en active Active
- 2008-07-15 WO PCT/EP2008/005767 patent/WO2009010270A2/en active Application Filing
- 2008-07-15 BR BRPI0813830-3A2A patent/BRPI0813830A2/pt not_active Application Discontinuation
- 2008-07-15 RU RU2010105303/04A patent/RU2476439C2/ru active
- 2008-07-15 AT AT08784775T patent/ATE556086T1/de active
- 2008-07-15 PT PT08784775T patent/PT2178900E/pt unknown
- 2008-07-15 AU AU2008277887A patent/AU2008277887B2/en active Active
- 2008-07-15 ES ES08784775T patent/ES2386323T3/es active Active
- 2008-07-15 CN CN2008800248048A patent/CN101889023B/zh active Active
- 2008-07-15 KR KR1020107003358A patent/KR101163297B1/ko active IP Right Grant
- 2008-07-15 JP JP2010516414A patent/JP5307808B2/ja active Active
- 2008-07-15 PE PE2008001193A patent/PE20090823A1/es active IP Right Grant
- 2008-07-16 TW TW097126983A patent/TWI363060B/zh active
- 2008-07-16 US US12/218,545 patent/US8138317B2/en active Active
-
2009
- 2009-12-24 IL IL202940A patent/IL202940A/en active IP Right Grant
-
2010
- 2010-01-14 ZA ZA2010/00283A patent/ZA201000283B/en unknown
-
2011
- 2011-01-24 US US12/931,070 patent/US8889837B2/en active Active
-
2013
- 2013-05-30 JP JP2013113940A patent/JP5814978B2/ja active Active
-
2018
- 2018-06-14 AR ARP180101676 patent/AR112300A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2178900T3 (pl) | Oczyszczanie PEGilowanych polipeptydów | |
| IL197221A0 (en) | Protein purification | |
| IL197220A0 (en) | Protein purification | |
| SI2220107T1 (sl) | Polipeptidi z dvojno afiniteto za čiščenje | |
| EP2054521A4 (en) | METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES | |
| GB0721686D0 (en) | Polypeptides | |
| SI3118220T1 (sl) | Protein | |
| ZA200810738B (en) | Polypeptide | |
| IL206158A0 (en) | Purification of not-glycosylated polypeptides | |
| GB0624227D0 (en) | Protein purification | |
| EP2123666A4 (en) | PEPTIDE | |
| GB0623539D0 (en) | Polypeptides | |
| GB0719231D0 (en) | Protein | |
| IL204881A0 (en) | Water purification | |
| GB0712302D0 (en) | Chrondroitinase polypeptides | |
| GB0703945D0 (en) | Peptide | |
| EP2097439A4 (en) | NEW PEPTIDE | |
| IL214252A0 (en) | Tetomilast polymorphs | |
| GB0720563D0 (en) | Protein | |
| EP2123751A4 (en) | NEW PEPTIDE | |
| IL206541A0 (en) | Novel protein | |
| GB0709027D0 (en) | Virus purification | |
| GB0719236D0 (en) | Protein | |
| GB0713302D0 (en) | Protein |